When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ATNX - FDA accepts Athenex application for oral paclitaxel for breast cancer
Athenex Inc.
Under Priority Review status, the FDA has accepted Athenex's (NASDAQ:ATNX) marketing application seeking approval of oral paclitaxel and encequidar (Oral Paclitaxel) for the treatment of metastatic breast cancer.
More news on: Athenex, Inc., Healthcare stocks news, Stocks on the move,